| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.09T | 1.13T | 1.11T | 1.13T | 911.43B |
| Gross Profit | 478.42B | 479.42B | 475.10B | 485.94B | 392.74B |
| EBITDA | 111.87B | 102.49B | 102.46B | 105.03B | 63.60B |
| Net Income | 30.27B | -47.48B | 4.52B | -103.15B | -26.12B |
Balance Sheet | |||||
| Total Assets | 1.23T | 1.22T | 1.39T | 1.41T | 1.34T |
| Cash, Cash Equivalents and Short-Term Investments | 110.76B | 89.90B | 127.13B | 180.57B | 117.67B |
| Total Debt | 398.31B | 438.17B | 522.58B | 568.29B | 448.65B |
| Total Liabilities | 685.93B | 743.56B | 834.67B | 913.90B | 776.62B |
| Stockholders Equity | 536.50B | 463.15B | 539.82B | 487.42B | 549.81B |
Cash Flow | |||||
| Free Cash Flow | 38.37B | 25.30B | 56.08B | -8.45B | -3.82B |
| Operating Cash Flow | 86.29B | 51.09B | 83.34B | 13.32B | 37.44B |
| Investing Cash Flow | -34.02B | 24.65B | -76.62B | -37.03B | -51.00B |
| Financing Cash Flow | -40.27B | -110.90B | -64.77B | 83.85B | 2.13B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥944.64B | 13.85 | 7.77% | 3.16% | 1.93% | 25.12% | |
79 Outperform | ¥777.43B | 16.69 | 10.50% | 2.03% | 3.03% | 26.77% | |
75 Outperform | ¥4.00T | 14.47 | 7.81% | 2.07% | 5.04% | 5.98% | |
70 Outperform | ¥34.56B | 3.43 | ― | 4.37% | -2.63% | 635.00% | |
67 Neutral | ¥826.32B | 14.91 | 6.04% | 2.78% | 3.18% | 24.19% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
54 Neutral | ¥293.19B | 9.95 | -12.69% | 0.71% | -3.56% | ― |